Rhenman & Partners Asset Management AB lessened its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 87.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,750 shares of the company's stock after selling 92,000 shares during the quarter. Rhenman & Partners Asset Management AB's holdings in Acadia Healthcare were worth $545,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of ACHC. Lindbrook Capital LLC boosted its position in Acadia Healthcare by 1,342.0% during the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after acquiring an additional 671 shares during the last quarter. Blue Trust Inc. grew its position in shares of Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares during the last quarter. Signaturefd LLC boosted its stake in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after buying an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp grew its holdings in Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after buying an additional 454 shares in the last quarter.
Acadia Healthcare Price Performance
ACHC traded down $2.61 on Thursday, hitting $26.49. 975,142 shares of the company were exchanged, compared to its average volume of 1,451,190. Acadia Healthcare Company, Inc. has a fifty-two week low of $25.41 and a fifty-two week high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market capitalization of $2.46 billion, a P/E ratio of 8.68, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13. The business's fifty day moving average is $33.96 and its 200 day moving average is $41.87.
Analysts Set New Price Targets
ACHC has been the topic of several analyst reports. Royal Bank of Canada reduced their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and upped their target price for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. KeyCorp dropped their target price on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a report on Monday, March 3rd. Finally, Bank of America decreased their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, Acadia Healthcare has an average rating of "Moderate Buy" and an average target price of $50.39.
Read Our Latest Stock Report on Acadia Healthcare
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
